跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IVOZFO - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
IVOZFO
Authorized
STANDARD
IVOZFO
Verity Pharmaceuticals Inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
86c4df6223d5152a
Company
Verity Pharmaceuticals Inc.
Type
Standard
Approval Details
Approval Id
86c4df6223d5152a
Drug Approval Canada Name
IVOZFO
Product Name
IVOZFO
Status
Marketed
Status Date
2020-02-12
Original Market Date
2020-02-12
Din
02488086
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
08:36.00
Atc Original
J01XX01 FOSFOMYCIN
Atc Name
j 01 xx 01
Aig Number
0137036004
Company Name
Verity Pharmaceuticals Inc.
Company Address
2560 Matheson Blvd. E., Suite 220, Mississauga, Ontario, Canada, L4W 4Y9
Company Detail Path
/organization/verity-pharmaceuticals-inc
Company Information
Pharmaceutical Company Name
Verity Pharmaceuticals Inc.
Country Name
Canada
Province Name
British Columbia
City Name
vancouver,british columbia,country_ca
Address
2600-595 Burrard St
Active Ingredients
FOSFOMYCIN (FOSFOMYCIN SODIUM)
4 G / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
86c4df6223d5152a
Type
Standard
Back to Health Canada Approvals